Growing community of inventors

Seoul, South Korea

Ye Seul Lim

Average Co-Inventor Count = 16.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Ye Seul LimSung Yun Cho (1 patent)Ye Seul LimHyun Jin Kim (1 patent)Ye Seul LimJong Yeon Hwang (1 patent)Ye Seul LimJae Du Ha (1 patent)Ye Seul LimChi Hoon Park (1 patent)Ye Seul LimPil Ho Kim (1 patent)Ye Seul LimSong Hee Lee (1 patent)Ye Seul LimJi Youn Park (1 patent)Ye Seul LimJe Ho Ryu (1 patent)Ye Seul LimHo Hyun Lee (1 patent)Ye Seul LimJung Min Ahn (1 patent)Ye Seul LimHee Jung Moon (1 patent)Ye Seul LimBeom Seon Suh (1 patent)Ye Seul LimSun Mi Yoo (1 patent)Ye Seul LimHan Wool Kim (1 patent)Ye Seul LimYe Seul Lim (1 patent)Sung Yun ChoSung Yun Cho (14 patents)Hyun Jin KimHyun Jin Kim (12 patents)Jong Yeon HwangJong Yeon Hwang (10 patents)Jae Du HaJae Du Ha (10 patents)Chi Hoon ParkChi Hoon Park (9 patents)Pil Ho KimPil Ho Kim (5 patents)Song Hee LeeSong Hee Lee (3 patents)Ji Youn ParkJi Youn Park (2 patents)Je Ho RyuJe Ho Ryu (2 patents)Ho Hyun LeeHo Hyun Lee (2 patents)Jung Min AhnJung Min Ahn (2 patents)Hee Jung MoonHee Jung Moon (1 patent)Beom Seon SuhBeom Seon Suh (1 patent)Sun Mi YooSun Mi Yoo (1 patent)Han Wool KimHan Wool Kim (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Korea Research Institute of Chemical Technology (1 from 624 patents)

2. Ubix Therapeutics, Inc. (1 from 2 patents)


1 patent:

1. 12161722 - Bifunctional heterocyclic compound having BTK degradation function via ubiquitin proteasome pathway, and use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/31/2025
Loading…